Welcome to our dedicated page for DOSEOLOGY SCIENCES news (Ticker: DOSEF), a resource for investors and traders seeking the latest updates and insights on DOSEOLOGY SCIENCES stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DOSEOLOGY SCIENCES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DOSEOLOGY SCIENCES's position in the market.
Doseology Sciences Inc. (OTCQB: DOSEF) announced the resignation of CEO Ralph Olson and Director David Lutz, effective March 31, 2023. Pratik Patel, the Company’s CFO, has been appointed as interim CEO. The Company has granted 2,450,000 stock options at an exercise price of $0.10 per share. The strategic alternatives process initiated on January 23, 2023, is still ongoing, with further updates to be provided as necessary. This transition occurs amid Doseology's ongoing focus on developing functional fungi products aimed at addressing mental health challenges.
Doseology Sciences Inc. (OTCQB: DOSEF) announced the appointment of Pratik (Tiki) Patel as the new Chief Financial Officer, effective March 3, 2023. Patel, a Chartered Professional Accountant with over 15 years of experience, replaces Peter Geh, who was thanked for his contributions. The CEO, Ralph Olson, expressed enthusiasm for Patel's financial expertise, emphasizing its potential positive impact on the company. Doseology focuses on mental health and wellness by developing innovative nutraceutical products utilizing functional fungi. The company aims to address mental health issues through its product line, available on its official website.
Doseology Sciences Inc. (CSE: MOOD, OTCQB: DOSEF) announced the termination of its lease in
Doseology Sciences Inc. has announced its approval for uplisting to the OTCQB Venture Market, effective July 6, 2022. Starting today, their shares will trade under the symbol DOSEF in the United States. This uplisting aims to enhance visibility and liquidity for investors. Doseology, which focuses on mental health and wellness through innovative products derived from functional fungi and plants, will continue trading on the Canadian Securities Exchange under the symbol MOOD and on the Frankfurt Stock Exchange as VU7.
Doseology Sciences Inc. has announced that its common shares are now approved for trading on the OTC Pink Open Market in the US under the symbol DOSEF. They will continue trading on the Canadian Securities Exchange and Frankfurt Stock Exchange under symbols MOOD and VU7 respectively. Furthermore, the Company applied for uplisting to the OTCQB Market. Doseology's shares also received eligibility for book-entry services through the Depository Trust Company, which is expected to enhance trading liquidity and accessibility for American investors, facilitating easier transactions.
FAQ
What is the current stock price of DOSEOLOGY SCIENCES (DOSEF)?
What is the market cap of DOSEOLOGY SCIENCES (DOSEF)?
